Gad Thomas
CHIEF BUSINESS OFFICER at Y-mAbs Therapeutics, Inc.
- Sold, on record
- $47.5M
- Dollars the filings state
- Form 4 sales
- 87
- Latest Mar 7, 2025
- Form 144 notices
- 3
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Y-mAbs Therapeutics, Inc.CHIEF BUSINESS OFFICER
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice Y-mAbs Therapeutics, Inc.NoticeDec 13 2023
Filed to sell 150,000 shares ($1M)
Gad Thomas, Officer
No 10b5-1 plan1.1x usual sizeFiling
- 2 Form 4 sale Y-mAbs Therapeutics, Inc.UnusualDec 15 +2 days
Sold 150,000 shares at $6.67 ($1M)
Gad Thomas, Chief Business Officer
No 10b5-1 planSold 36.1% of holdings ($2.8M position)265,032 shares left1.1x usual sizeFollows a Form 144Filing
- 3 Form 144 notice Y-mAbs Therapeutics, Inc.NoticeMar 5 +81 days
Filed to sell 3,900 shares ($64k)
Gad Thomas, Officer, Director
No 10b5-1 planFiling
- 4 Form 4 sale Y-mAbs Therapeutics, Inc.No planMar 5 same day
Sold 3,900 shares at $16.44 ($64k)
Gad Thomas, CHIEF BUSINESS OFFICER
No 10b5-1 planSold 2.4% of holdings ($2.7M position)158,700 shares leftFollows a Form 144Filing
- 5 Form 4 sale Y-mAbs Therapeutics, Inc.No planMay 23 +79 days
Sold 32,351 shares at $12.23 ($396k)
Gad Thomas, CHIEF BUSINESS OFFICER
No 10b5-1 planSold 12.2% of holdings ($3.2M position)232,681 shares left0.2x usual sizeFiling
- 6 Form 4 sale Y-mAbs Therapeutics, Inc.UnusualJun 11 +19 days
Sold 70,000 shares at $12.02 ($841k)
Gad Thomas, CHIEF BUSINESS OFFICER
No 10b5-1 planSold 30.1% of holdings ($2.8M position)162,681 shares left0.8x usual sizeFiling
- 7 Form 4 sale Y-mAbs Therapeutics, Inc.UnusualSep 16 +97 days
Sold 95,000 shares at $13.31 ($1.3M)
Gad Thomas, CHIEF BUSINESS OFFICER
No 10b5-1 planSold 58.4% of holdings ($2.2M position)67,681 shares left1.4x usual sizeFiling
- 8 Form 4 sale Y-mAbs Therapeutics, Inc.No planMar 7 +172 days
Sold 10,810 shares at $5.23 ($57k)
Gad Thomas, CHIEF BUSINESS OFFICER
No 10b5-1 planSold 5.1% of holdings ($1.1M position)202,721 shares left0.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (90)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2025 | Y-mAbs Therapeutics, Inc. | CHIEF BUSINESS OFFICER | Form 4 sale | 10,810 | $57k | 5.1% | No plan | SEC |
| Sep 16, 2024 | Y-mAbs Therapeutics, Inc. | CHIEF BUSINESS OFFICER | Form 4 sale | 95,000 | $1.3M | 58.4% | Unusual | SEC |
| Jun 11, 2024 | Y-mAbs Therapeutics, Inc. | CHIEF BUSINESS OFFICER | Form 4 sale | 70,000 | $841k | 30.1% | Unusual | SEC |
| May 23, 2024 | Y-mAbs Therapeutics, Inc. | CHIEF BUSINESS OFFICER | Form 4 sale | 32,351 | $396k | 12.2% | No plan | SEC |
| Mar 5, 2024 | Y-mAbs Therapeutics, Inc. | CHIEF BUSINESS OFFICER | Form 4 sale | 3,900 | $64k | 2.4% | No plan | SEC |
| Mar 5, 2024 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 144 notice | 3,900 | $64k | Notice | SEC | |
| Dec 15, 2023 | Y-mAbs Therapeutics, Inc. | Chief Business Officer | Form 4 sale | 150,000 | $1M | 36.1% | Unusual | SEC |
| Dec 13, 2023 | Y-mAbs Therapeutics, Inc. | Officer | Form 144 notice | 150,000 | $1M | Notice | SEC | |
| Nov 21, 2023 | Y-mAbs Therapeutics, Inc. | Chief Business Officer | Form 4 sale | 150,000 | $796k | 26.5% | Unusual | SEC |
| Nov 20, 2023 | Y-mAbs Therapeutics, Inc. | Officer | Form 144 notice | 150,000 | $791k | Notice | SEC | |
| Feb 9, 2022 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 281,170 | $2M | 33.2% | Unusual | SEC |
| Feb 4, 2022 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 136,164 | $1.1M | 13.9% | Unusual | SEC |
| Feb 1, 2022 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 8,000 | $81k | 13.8% | Plan not stated | SEC |
| Jan 24, 2022 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 88,055 | $936k | 8.2% | Unusual | SEC |
| Jan 21, 2022 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 183,085 | $2M | 14.6% | Unusual | SEC |
| Jan 19, 2022 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 77,814 | $853k | 60.9% | Unusual | SEC |
| Dec 7, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 54,000 | $901k | 3.8% | Unusual | SEC |
| Nov 30, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 47,607 | $815k | 3.2% | Unusual | SEC |
| Nov 23, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 50,000 | $853k | 50.0% | Unusual | SEC |
| Nov 16, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 4,000 | $77k | 0.3% | Plan not stated | SEC |
| Oct 29, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 4,000 | $99k | 0.3% | Plan not stated | SEC |
| Oct 15, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 4,000 | $109k | 0.3% | Plan not stated | SEC |
| Sep 30, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 4,000 | $113k | 0.3% | Plan not stated | SEC |
| Sep 15, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 4,000 | $135k | 0.3% | Plan not stated | SEC |
| Sep 2, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 50,000 | $1.7M | 3.2% | Unusual | SEC |
| Aug 17, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 29,000 | $851k | 1.8% | Unusual | SEC |
| Aug 3, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 4,000 | $135k | 0.3% | Plan not stated | SEC |
| Jul 20, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 4,000 | $130k | 0.3% | Plan not stated | SEC |
| Jul 7, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 4,000 | $127k | 0.3% | Plan not stated | SEC |
| Jun 30, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 4,000 | $135k | 0.3% | Plan not stated | SEC |
| Jun 14, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 4,000 | $143k | 0.2% | Plan not stated | SEC |
| May 28, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 4,000 | $148k | 0.2% | Plan not stated | SEC |
| May 18, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 4,000 | $136k | 0.2% | Plan not stated | SEC |
| Apr 26, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 7,000 | $196k | 100.0% | Unusual | SEC |
| Apr 12, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 11,000 | $293k | 100.0% | Unusual | SEC |
| Apr 1, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 15,000 | $454k | 100.0% | Unusual | SEC |
| Mar 15, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 11,000 | $405k | 100.0% | Unusual | SEC |
| Mar 1, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 15,000 | $533k | 100.0% | Unusual | SEC |
| Feb 16, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 11,000 | $518k | 100.0% | Unusual | SEC |
| Feb 1, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 11,000 | $462k | 100.0% | Unusual | SEC |
| Jan 19, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 11,000 | $512k | 100.0% | Unusual | SEC |
| Jan 5, 2021 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 11,000 | $543k | 100.0% | Unusual | SEC |
| Dec 28, 2020 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 7,000 | $364k | 100.0% | Unusual | SEC |
| Dec 16, 2020 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 7,000 | $371k | 100.0% | Unusual | SEC |
| Dec 14, 2020 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 4,000 | $212k | 0.6% | Plan not stated | SEC |
| Dec 11, 2020 | Y-mAbs Therapeutics, Inc. | Officer, Director | Form 4 sale | 100,000 | $5.1M | 100.0% | Unusual | SEC |
| Dec 1, 2020 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $206k | 0.6% | Plan not stated | SEC |
| Nov 16, 2020 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $185k | 0.6% | Plan not stated | SEC |
| Nov 2, 2020 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $175k | 0.6% | Plan not stated | SEC |
| Oct 15, 2020 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $157k | 0.6% | Plan not stated | SEC |
| Oct 1, 2020 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $156k | 0.6% | Plan not stated | SEC |
| Sep 15, 2020 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $163k | 0.6% | Plan not stated | SEC |
| Sep 14, 2020 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 50,000 | $2M | 100.0% | Unusual | SEC |
| Sep 1, 2020 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $166k | 0.6% | Plan not stated | SEC |
| Aug 17, 2020 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $161k | 0.6% | Plan not stated | SEC |
| Aug 12, 2020 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 50,000 | $2M | 7.1% | Unusual | SEC |
| Aug 3, 2020 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $146k | 0.6% | Plan not stated | SEC |
| Jul 15, 2020 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $160k | 0.6% | Plan not stated | SEC |
| Jul 1, 2020 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $168k | 0.6% | Plan not stated | SEC |
| Jun 15, 2020 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $174k | 0.6% | Plan not stated | SEC |
| Jun 4, 2020 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $166k | 0.6% | Plan not stated | SEC |
| May 27, 2020 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 50,000 | $2M | 6.5% | Unusual | SEC |
| May 18, 2020 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $159k | 0.5% | Plan not stated | SEC |
| May 12, 2020 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 50,000 | $2M | 6.0% | Unusual | SEC |
| May 1, 2020 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $129k | 0.5% | Plan not stated | SEC |
| Apr 13, 2020 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $118k | 0.5% | Plan not stated | SEC |
| Mar 16, 2020 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $72k | 0.5% | Plan not stated | SEC |
| Mar 2, 2020 | Y-mAbs Therapeutics, Inc. | President & Chairman | Form 4 sale | 4,000 | $117k | 0.5% | Plan not stated | SEC |
| Feb 18, 2020 | Y-mAbs Therapeutics, Inc. | President & Chairman | Form 4 sale | 4,000 | $131k | 0.5% | Plan not stated | SEC |
| Feb 10, 2020 | Y-mAbs Therapeutics, Inc. | President & Chairman | Form 4 sale | 4,000 | $132k | 0.5% | Plan not stated | SEC |
| Jan 27, 2020 | Y-mAbs Therapeutics, Inc. | President & Chairman | Form 4 sale | 4,000 | $140k | 0.5% | Plan not stated | SEC |
| Jan 13, 2020 | Y-mAbs Therapeutics, Inc. | President & Chairman | Form 4 sale | 4,000 | $124k | 0.5% | Plan not stated | SEC |
| Dec 16, 2019 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $126k | 0.5% | Plan not stated | SEC |
| Dec 2, 2019 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $130k | 0.5% | Plan not stated | SEC |
| Nov 18, 2019 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $114k | 0.5% | Plan not stated | SEC |
| Nov 4, 2019 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $120k | 0.5% | Plan not stated | SEC |
| Oct 21, 2019 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $110k | 0.5% | Plan not stated | SEC |
| Oct 7, 2019 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $101k | 0.4% | Plan not stated | SEC |
| Sep 16, 2019 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $122k | 0.4% | Plan not stated | SEC |
| Sep 3, 2019 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $103k | 0.4% | Plan not stated | SEC |
| Aug 19, 2019 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $111k | 0.4% | Plan not stated | SEC |
| Aug 5, 2019 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $87k | 0.4% | Plan not stated | SEC |
| Jul 22, 2019 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $90k | 0.4% | Plan not stated | SEC |
| Jul 8, 2019 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $90k | 0.4% | Plan not stated | SEC |
| Jun 24, 2019 | Y-mAbs Therapeutics, Inc. | President and Chariman | Form 4 sale | 4,000 | $87k | 0.4% | Plan not stated | SEC |
| Jun 10, 2019 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $91k | 0.4% | Plan not stated | SEC |
| Jun 3, 2019 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 4,000 | $80k | 0.4% | Plan not stated | SEC |
| May 28, 2019 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 6,000 | $121k | 0.6% | Plan not stated | SEC |
| May 13, 2019 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 6,000 | $124k | 0.6% | Plan not stated | SEC |
| Apr 11, 2019 | Y-mAbs Therapeutics, Inc. | President and Chairman | Form 4 sale | 250,000 | $6.5M | 21.0% | Plan not stated | SEC |